PHARMACY

FDA approves new labeling for ViroPharma’s Vancocin

BY Alaric DeArment

EXTON, Pa. — ViroPharma has received approval for updated labeling to its antibiotic drug.

The drug maker announced that the Food and Drug Administration approved the "modernization" of labeling for Vancocin (vancomycin hydrochloride) capsules. The new label includes clinical safety and efficacy data for the drug in treatment strains of Clostridium difficile bacteria currency circulating.

"This new label provides physicians a better understanding about how to treat and monitor patients suffering from the serious and often life-threatening infections that require oral Vancocin therapy," ViroPharma president and CEO Vincent Milano said.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Medbox acquires Prescription Vending Machines

BY Alaric DeArment

HOLLYWOOD, Calif. — Medbox has acquired Prescription Vending Machines and will operate it as a wholly owned subsidiary, Medbox said.

Founded in 2008, Prescription Vending Machines makes a biometric medicine dispensing system that can dispense drugs available form pharmacies, doctors’ offices, hospitals, urgent care centers and alternative medicine clinics. The company has installed more than 100 machines and point of sale systems worldwide.

Financial details of the acquisition were not given, but Prescription Vending Machines has had more than $6 million in sales since 2010.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Rule issued by Obama administration seeks to reduce, prevent drug shortages

BY Allison Cerra

WASHINGTON — The Obama administration on Thursday issued an interim final rule that will help prevent prescription drug shortages.

The rule, the administration said, will require manufacturers (that are the sole producer of certain critical drugs) to report to the Food and Drug Administration all interruptions in manufacturing of products.

"Shortages delay or deny needed care for patients and FDA is committed to making sure that patients and health professionals have the drugs they need when they need them," FDA commissioner Margaret Hamburg said. "We will continue to take steps such as issuing this interim final rule to prevent and reduce current and future disruptions in the supply of lifesaving medicines."

Details of the rule can be found here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES